Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mangesh Tiwaskar

Showing results (91-100 of 160) with videos related to

Pageof 16
Sort By:
The Journal of the Association of Physicians of India|July 14, 2022
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes MellitusVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India|June 25, 2023
An Expert Group Consensus Statement on "Approach and Management of Prediabetes in India"Ashok Kumar Das, Viswanathan Mohan, Ambady Ramachandran, et al.
The Journal of the Association of Physicians of India|September 29, 2019
Management of Diabetes during Fasting and Feasting in IndiaBanshi Saboo, Shashank Joshi, Siddharth N Shah, et al.
International Journal of Endocrinology|March 6, 2023
Expert Opinion on the Diagnosis and Management of Male Hypogonadism in IndiaSanjay Kalra, Jubbin Jacob, A G Unnikrishnan, et al.
The Journal of the Association of Physicians of India|December 4, 2019
Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic DrugsA G Unnikrishnan, Banshi Saboo, Shashank Joshi, et al.
The Journal of the Association of Physicians of India|September 29, 2019
Efficacy of DPP4i as the Fourth Drug in the Management of Type2 Diabetes Mellitus in Asian Indians Poorly Controlled by Use of at least 3 Oral Antidiabetic DrugsVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India|July 11, 2024
Prevalence and Association of Risk Factors According to Liver Steatosis and Fibrosis Stages among Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus in India: A Cross-sectional StudyVijay Panikar, Apoorva Gupta, Nikhil Nasikkar, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Scope of Pre- and Probiotics as an Add-on to Proton-pump Inhibitors in Various Clinical IndicationsSanjay Kalra, Ameya Joshi, Mangesh Tiwaskar, et al.
Clinics and Practice|November 29, 2021
Quantifying Remission Probability in Type 2 Diabetes MellitusSanjay Kalra, Ganapathi Bantwal, Nitin Kapoor, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Fortifying Micronutrient Supplementation in India: Indian Expert consensusBanshi Saboo, Amit Gupta, Mangesh Tiwaskar, et al.
Pageof 16

Showing results (91-100 of 160) with videos related to

Sort By:
Pageof 16
The Journal of the Association of Physicians of India|July 14, 2022
Study of the Efficacy of Uptitrating Teneligliptin Dose from Standard Dose (20 mg) to High Dose (40 mg) in Patients with Type II Diabetes MellitusVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India|June 25, 2023
An Expert Group Consensus Statement on "Approach and Management of Prediabetes in India"Ashok Kumar Das, Viswanathan Mohan, Ambady Ramachandran, et al.
The Journal of the Association of Physicians of India|September 29, 2019
Management of Diabetes during Fasting and Feasting in IndiaBanshi Saboo, Shashank Joshi, Siddharth N Shah, et al.
International Journal of Endocrinology|March 6, 2023
Expert Opinion on the Diagnosis and Management of Male Hypogonadism in IndiaSanjay Kalra, Jubbin Jacob, A G Unnikrishnan, et al.
The Journal of the Association of Physicians of India|December 4, 2019
Consensus Statement on Use of Ambulatory Glucose Profile in Patients with Type 2 Diabetes Mellitus Receiving Oral Antidiabetic DrugsA G Unnikrishnan, Banshi Saboo, Shashank Joshi, et al.
The Journal of the Association of Physicians of India|September 29, 2019
Efficacy of DPP4i as the Fourth Drug in the Management of Type2 Diabetes Mellitus in Asian Indians Poorly Controlled by Use of at least 3 Oral Antidiabetic DrugsVijay Panikar, Shashank Joshi, Mangesh Tiwaskar, et al.
The Journal of the Association of Physicians of India|July 11, 2024
Prevalence and Association of Risk Factors According to Liver Steatosis and Fibrosis Stages among Nonalcoholic Fatty Liver Disease Patients with Type 2 Diabetes Mellitus in India: A Cross-sectional StudyVijay Panikar, Apoorva Gupta, Nikhil Nasikkar, et al.
The Journal of the Association of Physicians of India|May 13, 2024
The Scope of Pre- and Probiotics as an Add-on to Proton-pump Inhibitors in Various Clinical IndicationsSanjay Kalra, Ameya Joshi, Mangesh Tiwaskar, et al.
Clinics and Practice|November 29, 2021
Quantifying Remission Probability in Type 2 Diabetes MellitusSanjay Kalra, Ganapathi Bantwal, Nitin Kapoor, et al.
The Journal of the Association of Physicians of India|June 17, 2024
Fortifying Micronutrient Supplementation in India: Indian Expert consensusBanshi Saboo, Amit Gupta, Mangesh Tiwaskar, et al.
Pageof 16